Stock analysts at StockNews.com assumed coverage on shares of Mannatech (NASDAQ:MTEX – Get Free Report) in a note issued to investors on Friday. The brokerage set a “buy” rating on the stock.
Mannatech Stock Performance
Shares of MTEX opened at $7.30 on Friday. Mannatech has a fifty-two week low of $7.30 and a fifty-two week high of $15.10. The stock has a fifty day moving average of $8.39 and a two-hundred day moving average of $8.64. The company has a debt-to-equity ratio of 0.09, a quick ratio of 0.51 and a current ratio of 1.07. The company has a market capitalization of $13.76 million, a PE ratio of -6.08 and a beta of 1.18.
Mannatech (NASDAQ:MTEX – Get Free Report) last posted its quarterly earnings data on Thursday, March 28th. The company reported ($0.94) EPS for the quarter. Mannatech had a negative net margin of 1.70% and a negative return on equity of 19.19%. The company had revenue of $32.69 million for the quarter.
Mannatech Company Profile
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
Featured Stories
- Five stocks we like better than Mannatech
- Airline Stocks – Top Airline Stocks to Buy Now
- Roblox: The Bottom Just Fell Out of the Metaverse
- What Investors Need to Know to Beat the Market
- Airbnb Stock Plummets After Earnings, But is It a Buy?
- Want to Profit on the Downtrend? Downtrends, Explained.
- Uber’s Earnings Drop Is Investors Opportunity
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
